These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat. Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150 [TBL] [Abstract][Full Text] [Related]
3. Centrally administered isoproterenol induces sympathetic outflow via brain prostaglandin E2-mediated mechanisms in rats. Ando K; Kondo F; Yamaguchi N; Tachi M; Fukayama M; Yoshikawa K; Gosho M; Fujiwara Y; Okada S Auton Neurosci; 2015 May; 189():1-7. PubMed ID: 25549851 [TBL] [Abstract][Full Text] [Related]
4. Possible role of adrenoceptors in the hypothalamic paraventricular nucleus in corticotropin-releasing factor-induced sympatho-adrenomedullary outflow in rats. Okada S; Yamaguchi N Auton Neurosci; 2017 Mar; 203():74-80. PubMed ID: 28202248 [TBL] [Abstract][Full Text] [Related]
5. Thromboxane A Tachi M; Yamaguchi N; Okada S Eur J Pharmacol; 2020 May; 875():173034. PubMed ID: 32097659 [TBL] [Abstract][Full Text] [Related]
7. Central Blockade of E-Prostanoid 3 Receptor Ameliorated Hypertension Partially by Attenuating Oxidative Stress and Inflammation in the Hypothalamic Paraventricular Nucleus of Spontaneously Hypertensive Rats. Wang FF; Ba J; Yu XJ; Shi XL; Liu JJ; Liu KL; Fu LY; Su Q; Li HB; Kang KB; Yi QY; Wang SQ; Gao HL; Qi J; Li Y; Zhu GQ; Kang YM Cardiovasc Toxicol; 2021 Apr; 21(4):286-300. PubMed ID: 33165770 [TBL] [Abstract][Full Text] [Related]
8. C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type. Lacroix S; Valliéres L; Rivest S J Neuroimmunol; 1996 Nov; 70(2):163-79. PubMed ID: 8898725 [TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone mediates suppression of pulsatile luteinizing hormone secretion induced by activation of alpha-adrenergic receptors in the paraventricular nucleus in female rats. Tsukamura H; Nagatani S; Cagampang FR; Kawakami S; Maeda K Endocrinology; 1994 Mar; 134(3):1460-6. PubMed ID: 8119187 [TBL] [Abstract][Full Text] [Related]
11. Elevation of plasma noradrenaline levels in urethane-anaesthetized rats by activation of central prostanoid EP3 receptors. Yokotani K; Nishihara M; Murakami Y; Hasegawa T; Okuma Y; Osumi Y Br J Pharmacol; 1995 Jun; 115(4):672-6. PubMed ID: 7582489 [TBL] [Abstract][Full Text] [Related]
12. The PGE2 receptor EP3 plays a positive role in the activation of hypothalamic-pituitary-adrenal axis and neuronal activity in the hypothalamus under immobilization stress. Lv L; Bai D; Ma Y; Liu K; Ma Y Brain Res Bull; 2021 Mar; 168():45-51. PubMed ID: 33370588 [TBL] [Abstract][Full Text] [Related]
13. c-Jun N-terminal Kinase mediates prostaglandin-induced sympathoexcitation in rats with chronic heart failure by reducing GAD1 and GABRA1 expression. Wang R; Zhang W; Dong Z; Qi Y; Hultström M; Zhou X; Lai EY Acta Physiol (Oxf); 2017 Feb; 219(2):494-509. PubMed ID: 27439062 [TBL] [Abstract][Full Text] [Related]
14. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF. Mansi JA; Rivest S; Drolet G Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325 [TBL] [Abstract][Full Text] [Related]
15. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes. Matsuoka Y; Furuyashiki T; Bito H; Ushikubi F; Tanaka Y; Kobayashi T; Muro S; Satoh N; Kayahara T; Higashi M; Mizoguchi A; Shichi H; Fukuda Y; Nakao K; Narumiya S Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4132-7. PubMed ID: 12642666 [TBL] [Abstract][Full Text] [Related]
16. Role of brain nicotinic acetylcholine receptor in centrally administered corticotropin-releasing factor-induced elevation of plasma corticosterone in rats. Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Lianyi L; Wakiguchi H; Yokotani K Eur J Pharmacol; 2008 Jun; 587(1-3):322-9. PubMed ID: 18423439 [TBL] [Abstract][Full Text] [Related]